Aktuelles

header
“HIV-TB comorbidity - current challanges and strategies”
20./21.03.2014 Berlin

Both, HIV and Mycobacterium tuberculosis, belong to the biggest killers and account for millions of deaths year by year. In recent years, coinfection with both pathogens not only occurs in Subsaharan Africa, but also at tremendously increasing speed in Eastern Europe and Central Asia where the problem of multidrug-resistant tuberculosis already makes an efficient tuberculosis control virtually impossible. Although the development of new strategies, new diagnostic tools and new drugs to fight tuberculosis is currently speeding up, HIV-TB comorbidity together with multidrug-resistance are two challenges that require an even faster counter-action. The past years saw increased efforts in research in diagnostics, therapy and prevention, also thanks to an increased engagement of non-governmental organizations and a fruitful collaboration with private companies. The eighth scientific symposium on World Tuberculosis Day will review the current epidemiological situation and present the newest insights in how to fight HIV-TB comorbidity in high- and low-burden settings.

 

Organization:

Timo Ulrichs,

Koch-Metchnikov-Forum, Langenbeck-Virchow-House, Luisenstr. 59, 10117 Berlin, Germany, and

Akkon University for Human Sciences, Am Köllnischen Park 1, 10179 Berlin, Germany;

Secretariat: Sven Stabroth, stabroth@kmforum.eu, Tel.: +49-30-2345-7722

 

Venue:               

Langenbeck-Virchow-Haus, Luisenstr. 59, 10117 Berlin, Germany

 

Time:   

Thursday, March 20, 2014: opening, first scientific day; reception;

Friday, March 21, 2014: scientific symposium, second scientific day

 

Registration:

Participation is free of charge; registration at the KMF secretariat is mandatory.

 

 

In cooperation with: WHO-Euro, Copenhagen; Stop TB Partnership; Stop TB Forum Germany, Berlin; Charité University Medicine, Berlin; Central Tuberculosis Research Institute, Moscow, Russia; Institute for Public Health, Ministry of Health, Moscow, Russia; Institutes for Tuberculosis in Smolensk, Voronezh, Yekaterinburg, Russia; Institute for Phthisiopulmonology Chiril Draganiuc, Moldova; Institute for Tuberculosis, Tbilisi State Medical University, Georgia.

 

Partners:

 

Becton Dickinson Diagnostics, Hain Lifescience, vfa, Otsuka

 

In 2014, the Koch-Mechnikov-Forum organizes the tuberculosis symposium on occasion of the World Tuberculosis Day in close cooperation with the World Health Summit. Its results will be reported and discussed at the next World Health Summit in Berlin, held in October 2014.

 

Thursday, March 20th, 2014

 

14.00h                  Welcome remarks and political framework

H. Hahn, Koch-Mechnikov-Forum (KMF), Berlin

M. van den Boom, WHO Euro office, Copenhagen

D. Ganten, World Health Summit, Berlin

I. A. Vasilyeva, Tuberculosis specialist of the Russian Federal Government, CTRI Moscow

T. Bauer, German Central Committee Against Tuberculosis (DZK), Berlin

 

14.30h                   Session 1: General aspects of tuberculosis and HIV/AIDS, epidemiology

                                Chairs: M. van den Boom, Copenhagen; T. Ulrichs, Berlin

M. van den Boom, WHO-Euro, Copenhagen

J. van der Meer, AFEW, AIDS Foundation East-West, Amsterdam: TB/HIV co-infection in Eastern Europe and Central Asia: challenges and opportunities

B. Karo, RKI, Berlin: Tuberculosis in people living with HIV/AIDS in Germany: current situation and gaps of knowledge

I. A. Vasilyeva, Tuberculosis specialist of the Russian Federal Government, CTRI Moscow: Epidemiology of TB and TB/HIV in the Russian Federation

 

16.10h                   Coffee break

 

16.40h                   Session 2: State of the art in diagnostics

Chairs: S. Rüsch-Gerdes, Borstel; D. Siewert, Heidelberg

P. Kaspar, FIND, Geneva: Addressing bottlenecks in TB diagnostics development

P. Azarschab, Hain Lifesciences, Nehren: Trends in TB Diagnostics

S. Rüsch-Gerdes, FZ-Borstel, Germany: Rapid Detection of Drug Resistance: Why? When? And How?

                                D. Siewert, Becton-Dickinson-Diagnostics, Heidelberg: Molecular Methods detecting higher rate of MDR - How to make the demanded 2nd Line Drugs Susceptibility Test easier in the lab routine

 

18.00h              Reception in the lobby of the Langenbeck-Virchow-House

 

Friday, March 21st, 2014

 

09:00h              Session 3: Country reports and experiences with fighting MDR-TB and HIV-TB comorbidity

Chairs: A. Skrahina, Minsk; H. Hahn, Berlin

T. Avdeeva, T. Myakisheva, Smolensk State Medical Academy, Smolensk: Scientific potential of a joint international interdisciplinary pilot project to fight against tuberculosis (Koch-Mechnikov Forum - Smolensk State Medical Academy)

U. Nanava, NTP of Georgia, Tbilisi: The Management of TB-HIV co-infection in Georgia

A. Skrahina, TB-Institute, Minsk: New challenge for Belarus: overlapping HIV and M/XDR-TB epidemics

V. Vilc, V. Crudu, L. Domente, Institute for TB control Chiril Draganiuc, Chisinau: Multidrug-resistant tuberculosis with mixed strains: a challenge in diagnostic and treatment of TB patientsD. Vakrusheva, Institute for Phthisiopulmonology, Yekaterinburg: Coinfection HIV/TB in a large industrial region of Russia

V. Puzanov, Central TB Research Institute, Moscow: Microbiological diagnostics in the Russian Federation – efficacy, quality, problems

11.00h                  Coffee break with poster viewing

11.30h              Session 4: (Basic) research and development: How to address the problem

Chair: T. Ulrichs, Berlin

                                G. Kosmiadi, CTRI, Moscow: Immunological aspects of host pathogen interaction in human tuberculous lung tissue

                                A. Ginsberg, AERAS Global Vaccine Foundation: Current Approaches and Progress in TB Vaccine Development

 

13.00h                  Lunch break with poster viewing

14.00h              Session 5: State of the art in treatment

 Chairs:  G. Günther, Borstel

R. Otto-Knapp, Central Committee against Tuberculosis, Berlin, Germany: title to follow

G. Günther, Research Center Borstel: Treatment recommendations of TB-HIV in Germany

S. Dietrich, Médecins sans Frontières, Berlin: Experiences of treating MDR-TB and TB-HIV-coinfections

15.20h                  Coffee break with poster viewing

 

15.50h                 Session 6: Panel discussion: How to address the problem in advocacy and awareness building

Chair:  M. Volland, Stop TB Forum, Berlin

M. Haase, Brot für die Welt, Berlin

H. Diekwisch, BUKO Pharma

                               B. Stikkers, KNCV, The Hague

17.00h                  Wrap-up and end of the symposium

 

 

 

23.-25.10.2017, St. Petersburg: VI. Kongress des Russischen Nationalen Verbandes für Lungenheilkunde


23.-27.10.2017, Jena: Besuch einer Delegation aus Wladimir des Universitätskliniums Jena (UKJ) mit dem Ziel, eine Kooperation zum Fach- und Schüleraustausch zwischen dem UKJ und der Wladimirer Medizinischen Fachschule zu starten